Compstatin TFA ethyl-5-methoxy-phenol 1-O-β-d-glucopyranosyl-(1 → 6)-β-d-glucopyranoside 6-Tridecylsalicylic acid

6-Tridecylsalicylic acid

ENMD-2076 has been shown to inhibit a distinct profile of angiogenic tyrosine kinase targets in addition to the Aurora A kinase

N'3-di(phenylcarbonothioyl)malonohydrazide

Varespladib

Compstatin TFA ethyl-5-methoxy-phenol 1-O-β-d-glucopyranosyl-(1 → 6)-β-d-glucopyranoside 6-Tridecylsalicylic acidCompstatin TFA, a 13 residue cyclic peptide, is a potent inhibitor of the complement system C3 with species specificity. Compstatin TFA binds to baboon C3 and is resistant to proteolytic cleavage in baboon blood (similar to humans). Compstatin TFA inhibits only the activation of primates complement system. Compstatin TFA exhibits IC50 values of 63 M and 12 M for classical and alterative complement pathway, respectively. Product information Molecular